Details for 2017800976

Up to date per 01.04.2026

Actions

Title / Product Name

VERFAHREN ZUR VORBEUGUNG VON KARDIOVASKULÄREN EREIGNISSEN DURCH PROTEINREDUKTION VON PROPROTEIN-KONVERTASE-SUBTILISIN-KEXIN 9 (PCSK9)

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017800976

EP Publication Number

3529360

E-Number

1677285

Language

PCT Number

US17057218

Publication Date

28.08.2019 A

17.04.2024 B1

Registration Date

17.04.2024

AT Publication Date

15.05.2024

Application Date

18.10.2017

Registration Number

Priorities

18.10.2016

201662409816 P

14.11.2016

201662422028 P

16.03.2017

201762472525 P

25.08.2017

201762550426 P

IPC

C12N 15/113 20100101AFI20180427BHEP

Maximum Duration of Protection

18.10.2037

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

WIJNGAARD, PeterLivingston New Jersey 07039 USA c/o The Medicines Company 8 Sylvan Way Parsippany NJ 07054US

KALLEND, DavidWollerau Kanton Schwyz 88321 Switzerland c/o The Medicines Company 8 Sylvan Way Parsippany NJ 07054US

Information about Fees